Literature DB >> 19198991

Combined autologous cellular cardiomyoplasty using skeletal myoblasts and bone marrow cells for human ischemic cardiomyopathy with left ventricular assist system implantation: report of a case.

Shigeru Miyagawa1, Goro Matsumiya, Toshihiro Funatsu, Masao Yoshitatsu, Naozumi Sekiya, Shinya Fukui, Takaya Hoashi, Masatsugu Hori, Hideki Yoshikawa, Yuzuru Kanakura, Jun Ishikawa, Katsuyuki Aozasa, Naomasa Kawaguchi, Nariaki Matsuura, Akira Myoui, Akifumi Matsuyama, Sachiko Ezoe, Hidehiro Iida, Hikaru Matsuda, Yoshiki Sawa.   

Abstract

Myocardial regeneration therapy shows great promise as a treatment for heart failure. We recently introduced combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells as a treatment for human ischemic cardiomyopathy. We report the results of our first clinical trial of this technique, used to treat a patient with severe heart failure caused by ischemic cardiomyopathy who was being managed with a left ventricular assist system (LVAS). After combined cell transplantation, the patient showed signs of improved cardiac performance and angiogenesis, and reduced fibrosis.

Entities:  

Mesh：

Year:  2009        PMID： 19198991     DOI： 10.1007/s00595-008-3803-x

Source DB:  PubMed          Journal:  Surg Today        ISSN： 0941-1291            Impact factor:   2.549


  7 in total

1.  Prolonged postischemic regional left ventricular delayed relaxation or diastolic asynchrony detected by color kinesis following coronary vasospasm.

Authors:  Katsuhisa Ishii; Kunihisa Miwa; Toshinori Makita; Nobuaki Okuda
Journal:  Am J Cardiol       Date:  2003-06-01       Impact factor: 2.778

2.  Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.

Authors:  Imran A Memon; Yoshiki Sawa; Shigeru Miyagawa; Satoshi Taketani; Hikaru Matsuda
Journal:  J Thorac Cardiovasc Surg       Date:  2005-09       Impact factor: 5.209

3.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

Authors:  Eriko Tateishi-Yuyama; Hiroaki Matsubara; Toyoaki Murohara; Uichi Ikeda; Satoshi Shintani; Hiroya Masaki; Katsuya Amano; Yuji Kishimoto; Kohji Yoshimoto; Hidetoshi Akashi; Kazuyuki Shimada; Toshiji Iwasaka; Tsutomu Imaizumi
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

4.  Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty.

Authors:  Shigeru Miyagawa; Yoshiki Sawa; Satoshi Taketani; Naomasa Kawaguchi; Toshikazu Nakamura; Nariaki Matsuura; Hikaru Matsuda
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

5.  Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.

Authors:  Nabil Dib; Robert E Michler; Francis D Pagani; Susan Wright; Dean J Kereiakes; Rose Lengerich; Philip Binkley; Diane Buchele; Inder Anand; Cory Swingen; Marcelo F Di Carli; James D Thomas; Wael A Jaber; Shaun R Opie; Ann Campbell; Patrick McCarthy; Michael Yeager; Vasken Dilsizian; Bartley P Griffith; Ronald Korn; Steven K Kreuger; Marwan Ghazoul; W Robb MacLellan; Gregg Fonarow; Howard J Eisen; Jonathan Dinsmore; Edward Diethrich
Journal:  Circulation       Date:  2005-09-20       Impact factor: 29.690

6.  Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.

Authors:  Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana A Silva; Andre L S Sousa; Claudio T Mesquita; Maria I D Rossi; Antonio C Carvalho; Helio S Dutra; Hans J F Dohmann; Guilherme V Silva; Luciano Belém; Ricardo Vivacqua; Fernando O D Rangel; Roberto Esporcatte; Yong J Geng; William K Vaughn; Joao A R Assad; Evandro T Mesquita; James T Willerson
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

7.  Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure.

Authors:  D M Mancini; A Beniaminovitz; H Levin; K Catanese; M Flannery; M DiTullio; S Savin; M E Cordisco; E Rose; M Oz
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690
  7 in total
  10 in total

1.  Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices.

Authors:  Deborah D Ascheim; Annetine C Gelijns; Daniel Goldstein; Lemuel A Moye; Nicholas Smedira; Sangjin Lee; Charles T Klodell; Anita Szady; Michael K Parides; Neal O Jeffries; Donna Skerrett; Doris A Taylor; J Eduardo Rame; Carmelo Milano; Joseph G Rogers; Janine Lynch; Todd Dewey; Eric Eichhorn; Benjamin Sun; David Feldman; Robert Simari; Patrick T O'Gara; Wendy C Taddei-Peters; Marissa A Miller; Yoshifumi Naka; Emilia Bagiella; Eric A Rose; Y Joseph Woo
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

2.  Effects of patient movement on measurements of myocardial blood flow and viability in resting ¹⁵O-water PET studies.

Authors:  Kazuhiro Koshino; Hiroshi Watabe; Junichiro Enmi; Yoshiyuki Hirano; Tsutomu Zeniya; Shinji Hasegawa; Takuya Hayashi; Shigeru Miyagawa; Yoshiki Sawa; Jun Hatazawa; Hidehiro Iida
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

3.  Clinical impact of combined transplantation of autologous skeletal myoblasts and bone marrow mononuclear cells in patients with severely deteriorated ischemic cardiomyopathy.

Authors:  Tomoyuki Fujita; Taichi Sakaguchi; Sigeru Miyagawa; Atsuhiro Saito; Naosumi Sekiya; Hironori Izutani; Yoshiki Sawa
Journal:  Surg Today       Date:  2011-07-20       Impact factor: 2.549

Review 4.  Myocardial regeneration of the failing heart.

Authors:  Alexander T Akhmedov; José Marín-García
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 5.  Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion.

Authors:  Kyriakos Anastasiadis; Polychronis Antonitsis; Helena Argiriadou; Georgios Koliakos; Argyrios Doumas; Andre Khayat; Christos Papakonstantinou; Stephen Westaby
Journal:  J Transl Med       Date:  2011-01-19       Impact factor: 5.531

6.  Advances in cell transplantation therapy for diseased myocardium.

Authors:  Outi M Villet; Antti Siltanen; Tommi Pätilä; M Ali A Mahar; Antti Vento; Esko Kankuri; Ari Harjula
Journal:  Stem Cells Int       Date:  2011-06-28       Impact factor: 5.443

Review 7.  The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy.

Authors:  Xianyun Wang; Jun Zhang; Fan Zhang; Jing Li; Yaqi Li; Zirui Tan; Jie Hu; Yixin Qi; Quanhai Li; Baoyong Yan
Journal:  Stem Cells Int       Date:  2015-05-26       Impact factor: 5.443

Review 8.  Regenerative medicine for the cornea.

Authors:  Yoshinori Oie; Kohji Nishida
Journal:  Biomed Res Int       Date:  2013-12-17       Impact factor: 3.411

Review 9.  Advanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon?

Authors:  Cheyenne C S Tseng; Faiz Z Ramjankhan; Nicolaas de Jonge; Steven A J Chamuleau
Journal:  Front Surg       Date:  2015-04-07

10.  A dual therapy of off-pump temporary left ventricular extracorporeal device and amniotic stem cell for cardiogenic shock.

Authors:  Toshinobu Kazui; Phat L Tran; Tia R Pilikian; Katie M Marsh; Raymond Runyan; John Konhilas; Richard Smith; Zain I Khalpey
Journal:  J Cardiothorac Surg       Date:  2017-09-07       Impact factor: 1.637
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.